Residents in eastern Congo cling to hope as a new Ebola treatment trial begins

Residents in eastern Congo's Ebola outbreak epicenter are hopeful as a clinical trial begins testing two experimental treatments, remdesivir and MBP134, to combat the Bundibugyo virus. The trial, led by the World Health Organization and international partners, aims to improve survival rates among infected patients and could expand to include high-risk groups.